 | Genuine Innovation & Regulatory Environment | Innovation must demonstrate one of the following are true in regards to its proposed solution: |
| | ■ | Significantly differs from existing offerings in the KSA: |
| | | √ | Innovator provides market research showing that there are few or no comparable offerings in the KSA. |
| | ■ | Offers a new use for existing technologies deployed in the KSA: |
| | | √ | Innovator produces a comparison of the key features of its technology or operating methodology against competitors showing clear differences. |
| | ■ | Represents a significant scale-up in existing technologies deployed in the KSA. |
 | Benefits stemming for the idea | Innovator must produce sufficient evidence showing that: |
| | ■ | The innovation proposed offers an identifiable and direct benefit or indirect benefits to consumers: |
| | | √ | (Research or simulation that shows potential security improvement, quality of service, lower prices, or increasing competition). |
| | | √ | The innovator is able to demonstrate that the innovation has the potential to improve access to the financial services markets (i.e. increase financial inclusion). |
| | ■ | It has adequately identified and addressed any risks for consumers and markets resulting from its proposed innovation |
| | | √ | The innovator is able to produce a comprehensive assessment of risk that the innovation can directly or indirectly pose to consumers as well as a mitigation plan to ensure consumers remain adequately protected throughout the testing. |
| | ■ | The innovator has sufficient resources in place to provide appropriate redress to consumers if required. |
 | MVP & Technology Readiness for Testing | As part of its application, the Innovator must produce a well-developed plan that at minimum contains: |
| | ■ | Timelines for execution including milestones for operational readiness and testing period: |
| | | √ | Innovator produces a comprehensive operational readiness and testing plan that identifies key milestones, a timeline, and likelihood of achieving target outcomes. |
| | ■ | Innovator is able to produce results of previous lab simulations carried out on its technology proposed. |
| | ■ | Innovator can demonstrate that the resources required to start testing can be successfully mobilized shortly after receiving Saudi Central Bank’s LoA. |
| | ■ | Reporting schedule stating the format and content (e.g. KPIs) of the report that will be submitted to Saudi Central Bank throughout the testing: |
| | | √ | Innovator proposes a schedule of periodic reports to be submitted to Saudi Central Bank during the test. |
| | | √ | Innovator proposes a clear and sufficient format for those reports that specifies the key metrics and parameters to be used and methodology for their analysis. |
| | ■ | Clear methodology of the testing and controls required. |
 | Exiting Plan | As part of its exiting strategy the Innovator must include a description of the future, development and deployment of the solution tested, including an explanation of: |
| | ■ | Innovator produces an Exit Strategy that clearly identifies the various possible end games of the testing exercise. |
| | | √ | How it intends to scale-up its innovation to a larger market should the testing be successful. |
| | | √ | How it intends to ensure that consumers do not suffer detriment as a result of unsuccessful testing. |
| | ■ | The Innovator’s exiting strategy contains details on the extra-resources needed to scale-up the technology to serve a larger market, estimated timescales and, if appropriate, plans to form strategic alliances with other firms. |
| | ■ | Innovator’s exiting strategy includes adverse scenarios that can lead it to suspend or cancel the test and a plan to ensure consumers are placed in the same position as if the test had not taken place. |